Frontiers in Psychiatry (Mar 2024)
Aerobic capacity and mitochondrial function in bipolar disorder: a longitudinal study during acute phases and after clinical remission
- Anna Giménez-Palomo,
- Anna Giménez-Palomo,
- Anna Giménez-Palomo,
- Anna Giménez-Palomo,
- Mariona Guitart-Mampel,
- Gemma Roqué,
- Ester Sánchez,
- Roger Borràs,
- Roger Borràs,
- Ana Meseguer,
- Francesc Josep García-García,
- Esther Tobías,
- Laura Valls-Roca,
- Gerard Anmella,
- Gerard Anmella,
- Gerard Anmella,
- Gerard Anmella,
- Marc Valentí,
- Marc Valentí,
- Marc Valentí,
- Marc Valentí,
- Luis Olivier,
- Luis Olivier,
- Luis Olivier,
- Luis Olivier,
- Oscar de Juan,
- Oscar de Juan,
- Oscar de Juan,
- Oscar de Juan,
- Iñaki Ochandiano,
- Iñaki Ochandiano,
- Iñaki Ochandiano,
- Iñaki Ochandiano,
- Helena Andreu,
- Helena Andreu,
- Helena Andreu,
- Helena Andreu,
- Joaquim Radua,
- Joaquim Radua,
- Joaquim Radua,
- Joaquim Radua,
- Norma Verdolini,
- Michael Berk,
- Michael Berk,
- Eduard Vieta,
- Eduard Vieta,
- Eduard Vieta,
- Eduard Vieta,
- Glòria Garrabou,
- Josep Roca,
- Xavier Alsina-Restoy,
- Isabella Pacchiarotti,
- Isabella Pacchiarotti,
- Isabella Pacchiarotti,
- Isabella Pacchiarotti
Affiliations
- Anna Giménez-Palomo
- Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain
- Anna Giménez-Palomo
- Bipolar and Depressive Disorders Unit, Institut d’Investigacions Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Catalonia, Spain
- Anna Giménez-Palomo
- Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Anna Giménez-Palomo
- Department of Medicine, School of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), Barcelona, Catalonia, Spain
- Mariona Guitart-Mampel
- Inherited Metabolic Diseases and Muscular Disorders Research Lab, Cellex-IDIBAPS, Faculty of Medicine and Health Sciences-University of Barcelona, Internal Medicine Department-Hospital Clinic of Barcelona and Centro de Investigación en Red de Enfermedades Raras (CIBERER), Catalonia, Spain
- Gemma Roqué
- Pneumology Department (ICR), Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Barcelona, Catalonia, Spain
- Ester Sánchez
- Pneumology Department (ICR), Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Barcelona, Catalonia, Spain
- Roger Borràs
- Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Roger Borràs
- Cardiovascular Institute, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat Autònoma de Barcelona, Barcelona, Spain
- Ana Meseguer
- Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain
- Francesc Josep García-García
- Inherited Metabolic Diseases and Muscular Disorders Research Lab, Cellex-IDIBAPS, Faculty of Medicine and Health Sciences-University of Barcelona, Internal Medicine Department-Hospital Clinic of Barcelona and Centro de Investigación en Red de Enfermedades Raras (CIBERER), Catalonia, Spain
- Esther Tobías
- Inherited Metabolic Diseases and Muscular Disorders Research Lab, Cellex-IDIBAPS, Faculty of Medicine and Health Sciences-University of Barcelona, Internal Medicine Department-Hospital Clinic of Barcelona and Centro de Investigación en Red de Enfermedades Raras (CIBERER), Catalonia, Spain
- Laura Valls-Roca
- Inherited Metabolic Diseases and Muscular Disorders Research Lab, Cellex-IDIBAPS, Faculty of Medicine and Health Sciences-University of Barcelona, Internal Medicine Department-Hospital Clinic of Barcelona and Centro de Investigación en Red de Enfermedades Raras (CIBERER), Catalonia, Spain
- Gerard Anmella
- Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain
- Gerard Anmella
- Bipolar and Depressive Disorders Unit, Institut d’Investigacions Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Catalonia, Spain
- Gerard Anmella
- Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Gerard Anmella
- Department of Medicine, School of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), Barcelona, Catalonia, Spain
- Marc Valentí
- Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain
- Marc Valentí
- Bipolar and Depressive Disorders Unit, Institut d’Investigacions Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Catalonia, Spain
- Marc Valentí
- Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Marc Valentí
- Department of Medicine, School of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), Barcelona, Catalonia, Spain
- Luis Olivier
- Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain
- Luis Olivier
- Bipolar and Depressive Disorders Unit, Institut d’Investigacions Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Catalonia, Spain
- Luis Olivier
- Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Luis Olivier
- Department of Medicine, School of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), Barcelona, Catalonia, Spain
- Oscar de Juan
- Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain
- Oscar de Juan
- Bipolar and Depressive Disorders Unit, Institut d’Investigacions Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Catalonia, Spain
- Oscar de Juan
- Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Oscar de Juan
- Department of Medicine, School of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), Barcelona, Catalonia, Spain
- Iñaki Ochandiano
- Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain
- Iñaki Ochandiano
- Bipolar and Depressive Disorders Unit, Institut d’Investigacions Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Catalonia, Spain
- Iñaki Ochandiano
- Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Iñaki Ochandiano
- Department of Medicine, School of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), Barcelona, Catalonia, Spain
- Helena Andreu
- Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain
- Helena Andreu
- Bipolar and Depressive Disorders Unit, Institut d’Investigacions Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Catalonia, Spain
- Helena Andreu
- Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Helena Andreu
- Department of Medicine, School of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), Barcelona, Catalonia, Spain
- Joaquim Radua
- Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain
- Joaquim Radua
- Bipolar and Depressive Disorders Unit, Institut d’Investigacions Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Catalonia, Spain
- Joaquim Radua
- Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Joaquim Radua
- Department of Medicine, School of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), Barcelona, Catalonia, Spain
- Norma Verdolini
- Local Health Unit Umbria 1, Department of Mental Health, Mental Health Center of Perugia, Perugia, Italy
- Michael Berk
- IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC, Australia
- Michael Berk
- 0Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, Orygen, The University of Melbourne, Melbourne, Australia
- Eduard Vieta
- Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain
- Eduard Vieta
- Bipolar and Depressive Disorders Unit, Institut d’Investigacions Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Catalonia, Spain
- Eduard Vieta
- Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Eduard Vieta
- Department of Medicine, School of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), Barcelona, Catalonia, Spain
- Glòria Garrabou
- Inherited Metabolic Diseases and Muscular Disorders Research Lab, Cellex-IDIBAPS, Faculty of Medicine and Health Sciences-University of Barcelona, Internal Medicine Department-Hospital Clinic of Barcelona and Centro de Investigación en Red de Enfermedades Raras (CIBERER), Catalonia, Spain
- Josep Roca
- Pneumology Department (ICR), Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Barcelona, Catalonia, Spain
- Xavier Alsina-Restoy
- Pneumology Department (ICR), Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Barcelona, Catalonia, Spain
- Isabella Pacchiarotti
- Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain
- Isabella Pacchiarotti
- Bipolar and Depressive Disorders Unit, Institut d’Investigacions Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Catalonia, Spain
- Isabella Pacchiarotti
- Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Isabella Pacchiarotti
- Department of Medicine, School of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), Barcelona, Catalonia, Spain
- DOI
- https://doi.org/10.3389/fpsyt.2024.1386286
- Journal volume & issue
-
Vol. 15
Abstract
BackgroundAerobic capacity has shown to predict physical and mental health-related quality of life in bipolar disorder (BD). However, the correlation between exercise respiratory capacity and mitochondrial function remains understudied. We aimed to assess longitudinally intra-individual differences in these factors during mood episodes and remission in BD.MethodsThis study included eight BD patients admitted to an acute psychiatric unit. Incremental cardiopulmonary exercise test (CPET) was conducted during acute episodes (T0), followed by constant work rate cycle ergometry (CWRCE) to evaluate endurance time, oxygen uptake at peak exercise (VO2peak) and at the anaerobic threshold. The second test was repeated during remission (T1). Mitochondrial respiration rates were assessed at T0 and T1 in peripheral blood mononuclear cells.ResultsEndurance time, VO2peak, and anaerobic threshold oxygen consumption showed no significant variations between T0 and T1. Basal oxygen consumption at T1 tended to inversely correlate with maximal mitochondrial respiratory capacity (r=-0.690, p=0.058), and VO2peak during exercise at T1 inversely correlated with basal and minimum mitochondrial respiration (r=-0.810, p=0.015; r=-0.786, p=0.021, respectively).ConclusionsOur preliminary data showed that lower basal oxygen consumption may be linked to greater mitochondrial respiratory capacity, and maximum oxygen uptake during the exercise task was associated with lower basal mitochondrial respiration, suggesting that lower oxygen requirements could be associated with greater mitochondrial capacity. These findings should be replicated in larger samples stratified for manic and depressive states.
Keywords